VPAC1 Receptors Key to New Prostate Cancer Diagnostic
In a validation study, researchers found that the new test had a sensitivity of 85% and specificity of 75%—both results superior to tests currently on the market.
Read More
Search Results for: prostate cancer
Myriad Supports New Guidelines Recommending Genetic Testing for Those with Breast Cancer
Study data demonstrate that about half of patients have clinically actionable mutations that are being missed.
Read More
New Assay is a Potential Alternative to Bone Marrow Biopsy
The liquid biopsy may enable clinical researchers to better understand tumor biology, particularly in early-stage disease.
Read More
Noninvasive Urine-Based Diagnostic Outperforms Blood Test and MRI for Prostate Cancer Detection
Combined with enhancing multiparametric MRI, the test could spare men from prostate biopsy.
Read More
National Cancer Institute Grants Support Liquid Biopsy Studies
With three NCI grants, BioFluidica is investigating chip-based liquid biopsy technologies for the detection of cancer and related genetic variants.
Read More